June 2010 Briefing - Ophthalmology
Here are what the editors at HealthDay consider to be the most important developments in Ophthalmology for June 2010. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Limbal Stem Cell Transplant Can Regrow Damaged Cornea
WEDNESDAY, June 23 (HealthDay News) -- Cultured limbal stem cells taken from an uninjured eye can be transplanted to a burn-damaged eye to regenerate new corneal epithelium, according to a study published online June 23 in the New England Journal of Medicine.
Early AMD Associated With Several Modifiable Risk Factors
WEDNESDAY, June 16 (HealthDay News) -- Early age-related macular degeneration (AMD) is associated with modifiable risk factors including smoking and high-density lipoprotein (HDL) cholesterol level, according to research published in the June issue of the Archives of Ophthalmology.
Healthy Diet Linked to Lower Risk of Nuclear Cataract
TUESDAY, June 15 (HealthDay News) -- The development of cataracts can be influenced by factors other than age, including diet and the use of sun-sensitizing medications combined with sun exposure, according to one study published in the June issue and another published online June 14 in the Archives of Ophthalmology.
Bevacizumab Is Effective and Safe in Macular Degeneration
FRIDAY, June 11 (HealthDay News) -- Bevacizumab (Avastin) appears to be a safe and efficacious alternative to standard care for the treatment of wet age-related macular degeneration (AMD), according to a study published June 10 in BMJ.
Parkinson's Disease Drug Can Cause Corneal Damage
WEDNESDAY, June 2 (HealthDay News) -- Parkinson's disease patients taking the drug amantadine are at risk for damage to the corneal endothelium and resulting impaired vision, which can become more pronounced the longer the drug is used, according to research published in Ophthalmology.
Antidepressants May Increase Cataract Risk in Elderly
WEDNESDAY, June 2 (HealthDay News) -- Older people who take selective serotonin reuptake inhibitors (SSRIs) may be at increased risk for developing cataracts, according to research published in Ophthalmology.